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Localization of amyloid-related replacements to a particular part of a protein molecule might be expected if these replacements function by modifying a region of the folded molecule's surface-increasing its tendency to aggregate, as has been suggested for the polymerization of hemoglobin S (15) . However, the mutations in transthyretin that are linked to amyloid formation in familial amyloidosis are distributed throughout the three-dimensional structure of the molecule (1) . Such a distribution resembles more closely that found for mutations that alter the folding stability of globular proteins (16, 17) . These and other observations have led to the speculation that particular mutations dispose proteins to amyloid formation by enhancing formation of a partially/ completely unfolded state that is responsible for fibril formation (18) . In fact, good evidence has recently been provided for the importance of an unfolding step in fibrillogenesis by transthyretin in familial amyloidosis (19, 20) . In this paper we report experiments that support the hypothesis that specific amino acid replacements play an important role in the development of AL by facilitating protein unfolding to generate an aggregation-prone nonnative state.
Amyloidosis is a disease characterized by the extracellular deposition offibrillar aggregates ofparticular proteins leading to cell loss, tissue disruption, and, in many cases, death (1, 2) . Although fundamental disease mechanisms are still unclear, a number of factors, such as elevated concentrations and/or limited proteolysis ofthe constituent protein, seem to interact synergistically in most types of amyloidosis. Extrinsic physiological factors often also play a major role (2) . In some forms, such as familial amyloidosis (1) and hereditary cerebral amyloid angiopathy (3), critical amino acid replacements are also important.
In light-chain (L-chain) amyloidosis (AL) (4-6), fibrils composed of L-chain variable region (VL) domains lead to malfunction of the kidney, heart, liver, and/or peripheral nervous system, with death generally occurring between 1 and 4 years after clinical diagnosis (7) . AL is associated with various conditions generating monoclonal L-chain overproduction, such as multiple myeloma. However, only 10-15% of myeloma patients develop AL (6) . Since L chains associated with AL differ in sequence from other L chains, disease mechanisms have been proposed that include a potential role for particular amino acid replacements (8) (9) (10) (11) (12) (13) (14) . Critical replacements have been difficult to confirm, however, and the EXPERIMENTAL PROCEDURES Production of VL Sequence Variants. The construction of DNA encoding residues 1-108 of REI VL from chemically synthesized oligonucleotides has been described (21 To test the hypothesis that these rare replacements play important roles in AL and do so by weakening domain stability, we constructed a series of six AL-associated singlepoint mutants in the VL domain of the Bence-Jones protein REI. Table 1 lists the sequence variants produced in this study and the names and subtypes of the amyloid-associated L chains in which they are found. S. J. Wood, R.W., and M.R.H., unpublished data). In contrast, the point mutants G57E, G68D, A84T, and R61N and the AL-unrelated mutant REI-RGD23 aggregate strongly in the in vitro model (Table 1) .
Since low pH is known to be destabilizing to most proteins (35) , the positive response of these mutants in the in vitro model system supports the hypothesis that critical amyloidogenic replacements function by destabilizing domain structure. To quantify this destabilization, we characterized the response of the mutants to Gdn HCI, by monitoring the unfolding-dependent increase in Trp-35 fluorescence due to the loss of quenching by the proximal disulfide bond (Fig. 2)  (22). Fig. 3 shows the results of these analyses as a series of plots representing the extent of unfolding of each protein as Gdn HCl, M (24) . Since the binding capacity of aggregate is assumed to be constant, this value reflects the amount of aggregate formed. C. is the midpoint of the Gdn HCI unfolding transition obtained from fitting the fluorescence data by the method of Santoro and Bolen (32) . The denaturation midpoint for RDG23 was estimated manually from the denaturation curve since there were no native baseline points to fit a formal Fwp plot (Fig. 3) . The Thermodynamic parameters could not be determined for RGD23 because an incomplete denaturation curve was obtained (Fig. 3) . Thermodynamic and in vitro aggregation data for four of the six replacements chosen for analysis, G57E, R61N, A84T, and G68D, support the hypothesis. The x-ray crystal structure of REI (Fig. 2) suggests reasonable explanations for their destabilizing effects, although a true accounting must await further experiments. The most destabilizing diseaserelated replacement, R61N, would be expected to eliminate or decrease the potential for a conserved salt bridge/H-bond with in an adjacent loop. The A84T mutation is expected to place a hydrophilic hydroxyl group in a tight hydrophobic environment involved in the packing of the two (3-sheets of the molecule into a (-sandwich. The two mutated Gly residues are located at positions in the native structure with unusual 4,,r angles, suggesting peptide backbone conformations that are most energetically favored when occupied by Gly (35) . Any other residue at these positions might be expected to destabilize the protein due to the constraints of peptide bond configuration.
Although the minor effects on stability and aggregation of L78T and Y49F were initially disappointing, in retrospect these amino acid replacements should not have been chosen as strong candidates. The six replacements were originally selected for testing based on their rarity against only the K L-chain database. When the A chain database comparison was made later, the L78T (from an amyloidogenic A chain) and Y49F (from a K) replacements proved to be not so unusual, occurring at frequencies of 4.8 and 4.3%, respectively (Table 1) . Structurally, the surface-exposed side chain of residue 49 does not interact with other groups and is thus expected to play a relatively minor role in stability. The side chain of residue 78, however, makes van der Waals contact with Ala-13 in an adjacent loop in the wild-type structure and thus might have been expected to be more important.
A Model for the Role of Amino Acid Sequence In AL. A number of possible explanations for the hypothetical role of amino acid replacements in AL, such as hydrophilic -+ hydrophobic surface effects, conformational changes to generate altered states with enhanced tendencies to aggregate, enhanced susceptibility of the L chain to the proteolysis that generates VL, or enhanced stability of an amyloidogenic VL dimer, have been discussed (8-14, 27, 28) . This variety of speculations reflects the difficulties in assigning importance to residue replacements.
The data presented here suggest an alternative explanation for the role of amino acid replacements in AL based on the recognized in vitro relationship between unfolding and aggregation in many globular proteins (18, 37, 38 ). In our model, replacements that decrease the energetic barrier to unfolding would be expected to increase the population of a nonnative state (which may or may not be fully unfolded) required for amyloid fibril formation. Although the linkage of rare destabilizing replacements with AL supports this hypothesis, there are a number of outstanding issues, discussed below, that should be addressed in future studies.
The in vitro modelforfibrilformation. The low pH conditions of the in vitro fibrillization conditions are clearly nonphysiological, and we thus view this system simply as a useful heuristic tool. At the same time, it should be noted that involvement in amyloidogenesis of acidic lysosomal compartments has been suggested for AL (34, 39) and other amyloid systems (19, 40, 41) . It is also possible that some other, as yet poorly understood, denaturing conditions are involved in amyloidogenesis in vivo. In addition, less-stringent denaturing forces might be capable of inducing amyloid formation at very high protein concentrations or in the presence of severely destabilizing amino acid replacements.
Microscopic examination reveals that the aggregates generated in the in vitro model system described here are mixtures predominating in organized fibril-like structures but also containing lesser amounts ofamorphous deposits (R.W., unpublished data). This ability of a single VL domain to give rise to aggregates of differing morphologies mirrors the occasional clinical observation of simultaneous fibril (AL) and amorphous aggregates [L-chain deposition disease (4, 6) ] in the same patient (5) . It is very likely that domain stability also plays a major role in L-chain deposition disease (L.R.H. and R.W., unpublished data).
Possible roles of sequence and structure beyond domain folding stability. The demonstration of a critical role for destabilizing mutations does not rule out involvement of other sequence elements in other ways. For example, the ability ofthe proposed misfolded amyloidogenic intermediate to assemble into characteristic amyloid fibrils or other ordered or amorphous aggregates will almost certainly depend on sequence elements that become exposed after partial or complete unfolding (38) .
Our unfolding studies were conducted at concentrations at which wild-type REI VL is >80% monomeric (42) and, hence, primarily monitor the stability of the monomer. Mutations that disrupt or weaken the dimer interface would be expected to also destabilize VL, under appropriate conditions. For the energy derived from dimer formation to be a factor in amyloidosis, however, the VL or L chain concentration at the site of fibril formation would have to be quite high, given the Kd of 10-5 M typical for the VL dimer (43 Given this last possibility, it is in fact remarkable that such strong effects are seen for several of the replacements we tested, despite the fact that they were characterized in the context of REI, and not in the context of the AL-associated L chain in which they were identified. The most destabilizing mutation, R61N, occurs at a residue that is very highly conserved in both A and K databases ( Table 1 ). The three next most destabilizing replacements, A84T, G68D, and G57E, are found in amyloid-associated A L chains, yet their potential to destabilize the immunoglobulin fold is clearly observed in the REI K background. Note. While this manuscript was in review, we became aware of a study (44) demonstrating that VL domains associated with various forms of deposition disease-including amyloidosis-have a tendency to form soluble aggregates under native or mildly denaturing conditions, while benign domains exhibit only the monomer-dimer equilibrium normally associated with VL domains. These results would be compatible with our folding stability hypothesis if the aggregation observed by Myatt et al. (44) were due to the generation of an aggregation-prone nonnative state in native buffer by virtue of one or more destabilizing replacements. That the VL domain is capable of being destabilized to this extent and is at the same time relatively soluble despite this destabilization, is illustrated by REI-RGD23, which appears to be "30% unfolded in native buffer at pH 7 (see Fig. 3 ). Analysis of the folding stability of authentic amyloidassociated VL domains should address some of the above issues.
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